Cargando…

Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts

Detalles Bibliográficos
Autores principales:	Tuomilehto, Jaakko, Schwarz, Peter, Lindström, Jaana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes Treatments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632163/ https://www.ncbi.nlm.nih.gov/pubmed/21525457 http://dx.doi.org/10.2337/dc11-s222

Ejemplares similares

Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
por: Tuomilehto, Jaakko
Publicado: (2009)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2011)

Longitudinal Branched-Chain Amino Acids, Lifestyle Intervention, and Type 2 Diabetes in the Finnish Diabetes Prevention Study
por: Kivelä, Jemina, et al.
Publicado: (2022)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
por: Kamenicky, Peter, et al.
Publicado: (2023)

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
por: Garber, Alan J.
Publicado: (2011)

Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project
por: Rautio, Nina, et al.
Publicado: (2012)

Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond
por: Tuomilehto, Jaakko, et al.
Publicado: (2023)

The Pros and Cons of Diagnosing Diabetes With A1C
por: Bonora, Enzo, et al.
Publicado: (2011)

Sleep Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance: The Finnish Diabetes Prevention Study
por: Tuomilehto, Henri, et al.
Publicado: (2009)

Predictors of long term weight loss maintenance in patients at high risk of type 2 diabetes participating in a lifestyle intervention program in primary health care: The DE-PLAN study
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2018)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
por: Lebovitz, Harold E.
Publicado: (2011)

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
por: Miccoli, Roberto, et al.
Publicado: (2011)

Glucokinase Activators for Diabetes Therapy: May 2010 status report
por: Matschinsky, Franz M., et al.
Publicado: (2011)

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective
por: Garber, Alan J.
Publicado: (2011)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists
por: Sesti, Giorgio
Publicado: (2011)

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
por: Dicker, Dror
Publicado: (2011)

An Outline of the Allen Method
Publicado: (1919)

Characteristics of children on the autism spectrum who benefit the most from receiving intervention in inclusive versus specialised early childhood education settings
por: Vivanti, Giacomo, et al.
Publicado: (2022)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
por: Wijkman, Magnus O., et al.
Publicado: (2021)

Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2017)

Early Treatment for Women with Alcohol Addiction (EWA) Reduces Mortality: A Randomized Controlled Trial with Long-Term Register Follow-up
por: Gjestad, Rolf, et al.
Publicado: (2011)

Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes
por: Kujala, Urho M, et al.
Publicado: (2011)

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
por: Curtis, Jeffrey R, et al.
Publicado: (2019)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes – Role of Partner and Family Support
por: Gupta, Lovely, et al.
Publicado: (2019)

Reducing bureaucracy in clinical trials, now is the time!
por: Carmona, Loreto
Publicado: (2022)

Development of a Psychologically Enhanced Interactive Online Intervention for Hazardous Drinking
por: Linke, Stuart, et al.
Publicado: (2008)

The Impact of Brief Alcohol Interventions in Primary Healthcare: A Systematic Review of Reviews
por: O'Donnell, Amy, et al.
Publicado: (2014)

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)
por: Vakil, Deep, et al.
Publicado: (2021)

Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle
por: Alkhatib, Ahmad, et al.
Publicado: (2018)

Effective long-term temozolomide rechallenge in a macroprolactinoma
por: Zampetti, Benedetta, et al.
Publicado: (2018)

Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial
por: Sindi, Shireen, et al.
Publicado: (2020)

Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trial
por: Whitaker, Madelyn, et al.
Publicado: (2023)

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis
por: Lindström, Ulf, et al.
Publicado: (2019)

Predictors of individual differences in minimally verbal peer communication exchanges following peer‐oriented social intervention
por: Kedar, Maayan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8fnmpasebkhn7q1hpe3c04tk08